Theme: Innovative research and therapeutic approaches towards the Bipolar Disorder, Schizophrenia and Mental Disorders

Bipolar Disorders 2016

Bipolar Disorders 2016

We cordially welcome you to the International conference on Bipolar Disorder, Schizophrenia and Mental Disorders on October 26- 27, 2016 at Chicago, USA. Conference Series LLC organizes conference every year all around the world. We make the platform for global networking as it brings together renowned speakers and scientists across the world to a most exciting and memorable scientific events, filled with much enlightening interactive sessions, world class exhibitions and poster presentations.

In USA, 18.1% of adults experienced an anxiety disorder such as posttraumatic stress disorder, obsessive-compulsive disorder and specific phobias. Among the 20.2 million adults in the U.S.A. who experienced a substance use disorder, 50.5% i.e. 10.2 million adults, had a co-occurring mental illness.

 

This activity has been approved for AMA PRA Category 1 Credit ™

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and Conference Series, LLC. PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.

PeerPoint Medical Education Institute designates the live format for this educational activity for AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.

 

Track 1: Bipolar Disorders

The manic depressive illness which is also known as Bipolar Disorders are mental disorders that Specify by unusual elevated event of moods disorders, active level and energy. It is also characterize by ability to carry out the personal works and daily task. Bipolar Disorders symptoms are often acute. The acute symptoms are termed as mania or hypomania, based on their different from the normal downs and up that everyone goes through from time to time in their life time. The symptoms could cause a poor concentration, poor jobs and poor academic results, break up and divorce, and suicide is most common symptoms seen. Bipolar disorders patients could live full and healthy life; they could be treated well with help or proper medications and proper counselling with mental exercise. There are four features commonly seen on bipolar patients, those are also known as rapid cycling or as episodes of mania.

The bipolar disorder has been categorised into two different types i.e. bipolar disorders I is characterize by single manic episode; other is bipolar disorder II which is again characterized by both hypomanic episode major depressive episodes.

Related Bipolar Disorders ConferencesBipolar Disorders Congress Bipolar Disorders Events | Meetings on Bipolar Disorders

International Conference on Neurorehabilitation July 21-22, 2016 Brisbane, Australia, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2016 Vienna, Austria, International Conference on Neuroimaging and Interventional Radiology August 22-23, 2016 Vienna, Austria, 2nd International Conference on Autism, September 15-16, 2016 Phoenix, Arizona,USA, 2nd International Conference on Brain Disorders and Therapeutics, October 26-28, 2016 Chicago, USA, International conference on Bipolar Disorders, Schizophrenia and  Mental Disorders, DGNC — Annual Meeting of the German Society of Neurosurgery during June 12 – 15, 2016 at Frankfurt am Main, Germany, 7th International Regional Stress and Behaviour Neuroscience and Biopsychiatry Conference (North America) on June 22 – 24, 2016 at Miami Beach, USA, FENS FORUM 2016 on July 02 – 06, 2016 at Copenhagen, Denmark, The power of mathematics in contemporary neuroscience during July 11 – 15, 2016 at Marseille, France, YOKOHAMA-2016 on July 23 – 24, 2016 at Yokohama, Russia, Alternating Hemiplegia of Childhood Foundation and  Alzheimer’s Drug Discovery Foundation, Benign Essential Blepharospasm, Research Foundation and  Birth Defect Research for Children, Inc, Caregiver Action Netork and  Carter Centers for Brain Research in Holoprosencephaly, Dana Foundation and  Dandy-Walker Alliance, Alzheimer's Association and  Alzheimer's Foundation of America, Blaze Sports America and  Bluefield Project to Cure Frontotemporal Dementia
 

Track 2: Mental Disorders

Mental disorder is also known as mental illness. This is a diagnosis of mental patterns or personal behavioural that often causes sufferings and inability to perform proper day to day function in ordinary life. Such features may be relapsing, remitting and persistent.

There are so many causes for mental disorders but, those are rarely clear. At present there are numbers of definitions for mental disorders. Each of them is true to their definitions according to their conditions for the mental disorders. So, even its definition is not much specific and clear. Mental disorders are being defined by a combination of how a person thinks, feels, behaves and perceives.

Related  Mental Disorders Conference | Mental Disorders Congress Mental Disorders Events | Mental Disorders meetings

2nd International Conference on Sleep Disorders and Medicine, November 28-30, 2016 Atlanta, USA, 2nd International Conference on Parkinson’s Disease and  Movement Disorders, December 05-07, 2016 Phoenix, USA, 2nd International Conference on Central Nervous System Disorders and Therapeutics, December 05-07, 2016 Dubai, UAE, 4 International Conference on Vascular Dementia on June 30 - July 02, 2016 Valencia, Spain, International Conference and Exhibition on Dual Diagnosis, July 18-19, 2016 Chicago, Illinois, USA, International Conference on Neuro Oncology and Brain Tumor, July 21-22, 2016 Brisbane, Australia,DGNC — Annual Meeting of the German Society of Neurosurgery during June 12 – 15, 2016 at Frankfurt am Main, Germany, 7th International Regional Stress And Behaviour Neuroscience and Biopsychiatry Conference (North America) on June 22 – 24, 2016 at Miami Beach, USA, FENS FORUM 2016 on July 02 – 06, 2016 at Copenhagen, Denmark, The power of mathematics in contemporary neuroscience during July 11 – 15, 2016 at Marseille, France, YOKOHAMA-2016 on July 23 – 24, 2016 at Yokohama, Russia, Cerebral Palsy Foundation and  CHADD – Children and  Adults with Attention-Deficit/Hyperactivity DisorderDana Foundation and  Dandy-Walker AllianceFight SMA and  FOCUS FamiliesEpilepsy Foundation and  Epilepsy InstituteAmerican Association on Health and  Disability and  American Autoimmune Related Diseases Association

Track 3: Schizophrenia

Schizophrenia is a serious disorder which affects how a person thinks, feels and acts. Someone with schizophrenia may have difficulty distinguishing between what is Imaginary and what is real, they may have difficulty expressing normal emotions in social situations.

Contrary to public perception, schizophrenia is not split personality or multiple personality. The vast majority of people with schizophrenia are not violent and do not pose a danger to others. Schizophrenia is not caused by childhood experiences, poor parenting or lack of willpower, nor is the symptoms identical for each person. Schizophrenia has been divided into five subtypes based on their symptoms and diagnosis. Like all other mental disorders, the symptoms of Schizophrenia also changes in time to time. It causes difficult for a practitioner to classify the Schizophrenia. Thus, it cause problem for treating a patient efficiently. Subtyping system has favoured to solve this complex.

Related Schizophrenia ConferencesSchizophrenia Congress | Schizophrenia Events | Schizophrenia meetings

International Conference on Neurorehabilitation July 21-22, 2016 Brisbane, Australia, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2016 Vienna, Austria, International Conference on Neuroimaging and Interventional Radiology August 22-23, 2016 Vienna, Austria, 2nd International Conference on Autism, September 15-16, 2016 Phoenix, Arizona,USA, 2nd International Conference on Brain Disorders and Therapeutics, October 26-28, 2016 Chicago, USA, International conference on Bipolar Disorders, Schizophrenia and  Mental Disorders,10th International Neuroscience and Biological Psychiatry ISBS Regional on December 01- 03, 2016, at Rio de Janeiro, Brazil, Havana 2016 - 18th World Congress of Psychophysiology on August 31, 2016 - 04 September 2016 at Havana, Cuba, 9th International Regional Neuroscience and Biological Psychiatry Conference "Stress and Behaviour" (China and South East Asia) on October 27-29, 2016 at Zhanjiang, China, International Neuroscience and Biological Psychiatry ISBS Symposium "Translational Neuroscience Of Stress" on November 10 - 11, 2016 at San Diego, USA, Society for Neuroscience 2016 Annual Meeting on November 12 - 16, 2016 at San Diego, USA, 2016 Sleep Summit on November 22 - 24, 2016 at London, United Kingdom, Blaze Sports America and Bluefield Project to Cure Frontotemporal DementiaCharcot-Marie-Tooth Association and Charlie Foundation for Ketogenic TherapiesDavis Phinney Foundation and Disability ResourcesFamilial Dysautonomia Hope Foundation and Family Caregiver Alliance/ National Center on CaregivingEpilepsy Therapy Project and Exceptional Parent Magazine 

Tract 4: Psychiatry and Clinical Neuroscience

The term “Psychiatry” is referring to the branch of medicinal science that deals with study, diagnosis, treatment and prevention of mental disorders. This field covers numbers of mental abnormalities that are cognitive, behavioural and other perpetual psychiatry.
Clinical neuroscience is a branch of neuroscience that focuses on the fundamental mechanisms that underlie diseases and disorders of the brain and central nervous system. It seeks to develop new ways of diagnosing such disorders and ultimately of developing novel treatments.

Related Neurology ConferencesNeurology Congress | Neuroscience Events Neurologist Meeting

2nd International Conference on Sleep Disorders and Medicine, November 28-30, 2016 Atlanta, USA, 2nd International Conference on Parkinson’s Disease and  Movement Disorders, December 05-07, 2016 Phoenix, USA, 2nd International Conference on Central Nervous System Disorders and Therapeutics, December 05-07, 2016 Dubai, UAE, 4 International Conference on Vascular Dementia on June 30 - July 02, 2016 Valencia, Spain, International Conference and Exhibition on Dual Diagnosis, July 18-19, 2016 Chicago, Illinois, USA, International Conference on Neuro Oncology and Brain Tumor, July 21-22, 2016 Brisbane, Australia,10th International Neuroscience and Biological Psychiatry ISBS Regional on December 01- 03, 2016, at Rio de Janeiro, Brazil, Havana 2016 - 18th World Congress of Psychophysiology on August 31, 2016 - 04 September 2016 at Havana, Cuba, 9th International Regional Neuroscience and Biological Psychiatry Conference "Stress and Behaviour" (China and South East Asia) on October 27-29, 2016 at Zhanjiang, China, International Neuroscience and Biological Psychiatry ISBS Symposium "Translational Neuroscience Of Stress" on November 10 - 11, 2016 at San Diego, USA, Society for Neuroscience 2016 Annual Meeting on November 12 - 16, 2016 at San Diego, USA, 2016 Sleep Summit on November 22 - 24, 2016 at London, United Kingdom, Disabled American Veteransand  Disabled Sports USAFabry Supportand  Information Groupand  Facioscapulohumeral Muscular Dystrophy Children's Brain Disease Foundation and  Children's Brain Tumor FoundationDravet Syndrome Foundation and  Dysautonomia Foundation, Dysautonomia Youth Network of America, Inc. and Dystonia Medical Research Foundation

Track 5: Understanding Bipolar Disorders

Bipolar Disorders are very mysterious type of mental disorders. Till today the main of bipolar disorders have not been fully understood by researchers, scientist and clinician. It has been reported in some journals that, bipolar disease are seems to be a genetic hereditary. The similar proband and disorders symptoms have been seen in the siblings of bipolar disorders patients. Most of the time bipolar disorders are misunderstood and misdiagnosed due to its confusing and subtitling nature. Bipolar Disorders patients often suffer with lots of medications side effects and sever mistreatment. 

Related Bipolar Disorders ConferencesBipolar Disorders Congress Bipolar Disorders Events | Meetings on Bipolar Disorders

2nd International Conference on Sleep Disorders and Medicine, November 28-30, 2016 Atlanta, USA, 2nd International Conference on Parkinson’s Disease and  Movement Disorders, December 05-07, 2016 Phoenix, USA, 2nd International Conference on Central Nervous System Disorders and Therapeutics, December 05-07, 2016 Dubai, UAE, 4 International Conference on Vascular Dementia on June 30 - July 02, 2016 Valencia, Spain, International Conference and Exhibition on Dual Diagnosis, July 18-19, 2016 Chicago, Illinois, USA, International Conference on Neuro Oncology and Brain Tumor, July 21-22, 2016 Brisbane, Australia,10th International Neuroscience and Biological Psychiatry ISBS Regional on December 01- 03, 2016, at Rio de Janeiro, Brazil, Havana 2016 - 18th World Congress of Psychophysiology on August 31, 2016 - 04 September 2016 at Havana, Cuba, 9th International Regional Neuroscience and Biological Psychiatry Conference "Stress and Behaviour" (China and South East Asia) on October 27-29, 2016 at Zhanjiang, China, International Neuroscience and Biological Psychiatry ISBS Symposium "Translational Neuroscience Of Stress" on November 10 - 11, 2016 at San Diego, USA, Society for Neuroscience 2016 Annual Meeting on November 12 - 16, 2016 at San Diego, USA, 2016 Sleep Summit on November 22 - 24, 2016 at London, United Kingdom, Cerebral Palsy Foundation and  CHADD – Children and  Adults with Attention-Deficit/Hyperactivity Disorder, Dana Foundation and  Dandy-Walker Alliance, Fight SMA and  FOCUS Families, Epilepsy Foundation and  Epilepsy Institute, American Association on Health and  Disability and  American Autoimmune Related Diseases Association

Track 6: Progression in treatment of Bipolar Disorders

Innovative advancement in treatment modules and research are being carried out by psychotherapist, psychiatrist, neurologist and researchers. Gratefully, numbers of associations and research organisations are supporting and funding the researchers for their noble and innovative researches on bipolar disorders. One organization which is also known as the National Institute of Mental Health or NIMH is the world's leading neurology and psychiatrist research organization. They do focus, conducts and supports research on the treatment, cause, and proper diagnosis of metal disorders. There are different types of new and advance technique like behavioural approach system, Behavioural, inhibition system, System sensitivity, Impulsivity traits, Cognitive style, Screening procedures, Demographic and risk factors and New advances in drugs as well as medications which is being use for the treatment of bipolar disorders and other related mental disorders.

Related Bipolar Disorders ConferencesBipolar Disorders Congress Bipolar Disorders Events Meetings on Bipolar Disorders

International Conference on Neurorehabilitation July 21-22, 2016 Brisbane, Australia, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2016 Vienna, Austria, International Conference on Neuroimaging and Interventional Radiology August 22-23, 2016 Vienna, Austria, 2nd International Conference on Autism, September 15-16, 2016 Phoenix, Arizona,USA, 2nd International Conference on Brain Disorders and Therapeutics, October 26-28, 2016 Chicago, USA, International conference on Bipolar Disorders, Schizophrenia and  Mental Disorders, DGNC — Annual Meeting of the German Society of Neurosurgery during June 12 – 15, 2016 at Frankfurt am Main, Germany, 7th International Regional Stress And Behaviour Neuroscience and Biopsychiatry Conference (North America) on June 22-24, 2016 at Miami Beach, USA, FENS FORUM 2016 on July 02-06, 2016 at Copenhagen, Denmark, The power of mathematics in contemporary neuroscience on July 11-15, 2016 at Marseille, France, YOKOHAMA-2016 on July 23 – 24, 2016 at Yokohama, Russia, Blaze Sports America and Bluefield Project to Cure Frontotemporal Dementia, Charcot-Marie-Tooth Association and Charlie Foundation for Ketogenic Therapies, Davis Phinney Foundation and Disability Resources, Familial Dysautonomia Hope Foundation and Family Caregiver Alliance/ National Center on Caregiving, Epilepsy Therapy Project and Exceptional Parent Magazine 

Track 7: Prevention of Bipolar Disorder

There are numbers of diseases and mental disorders which could be prevented with ease. Unlike any other preventable disorders, bipolar disorders are not preventable and it is somewhat related to hereditary. Proper diagnosis and knowing the earliest sign could help lot more in treating bipolar disorders. Proper counselling and diagnosis and intervening between episodes can help to prevent bipolar disorders from worsening further. Many disorders like attention deficit hyperactivity disorder (ADHD), substance abuse and schizophrenia has reported to be disorders like bipolar disorder and with other mental disorders. Guidance for multifactorial risk model and education about bipolar disorders would help the people to do proper dealing with bipolar disorders patients.

Related Bipolar Disorders ConferencesBipolar Disorders Congress Bipolar Disorders Events Meetings on Bipolar Disorders

2nd International Conference on Sleep Disorders and Medicine, November 28-30, 2016 Atlanta, USA, 2nd International Conference on Parkinson’s Disease and  Movement Disorders, December 05-07, 2016 Phoenix, USA, 2nd International Conference on Central Nervous System Disorders and Therapeutics, December 05-07, 2016 Dubai, UAE, 4 International Conference on Vascular Dementia on June 30 - July 02, 2016 Valencia, Spain, International Conference and Exhibition on Dual Diagnosis, July 18-19, 2016 Chicago, Illinois, USA, International Conference on Neuro Oncology and Brain Tumor, July 21-22, 2016 Brisbane, Australi, DGNC — Annual Meeting of the German Society of Neurosurgery on June 12-15, 2016 at Frankfurt am Main, Germany, 7th International Regional Stress and Behaviour Neuroscience and Biopsychiatry Conference (North America) on June 22-24, 2016 at Miami Beach, USA, FENS FORUM 2016 on July 02 – 06, 2016 at Copenhagen, Denmark, The power of mathematics in contemporary neuroscience on July 11-15, 2016 at Marseille, France, YOKOHAMA-2016 on July 23-24, 2016 at Yokohama, Russia, American Behcet's Disease Associationand  American Brain Coalition, Fibromuscular Dysplasia Society of America and  Fibromyalgia Network, Brain Aneurysm Foundation and  Brain Injury Association of America, Inc., Brain Injury Resource Center and  Brain Trauma Foundation, Chiariand  Syringomyelia Foundation and  Childhood Brain Tumor Foundation

Track 8: Diagnosis and Neuroimaging of Bipolar Disorders

Diagnosis and neuroimaging of bipolar disorders became the most important factor in treating bipolar disorders patients. These systematic methods are used to identify the conditions of patients, manic episodes and acuteness of the bipolar disorders as well as the other sign and symptoms.

Diagnosis and neuroimaging often describes and denotes to the techniques that produce the internal images without surgery and without incision of the skin. It helps in getting internal image from any part of the body and organs without being direct contact with it. In other ways we can say that these technologies enable us to have a non-invasive visualization of the brain’s structure and functions. These techniques which are also known as neuroimaging became most useful device for both researchers and clinicians. Diagnosing and differentiating Schizophrenias and Bipolar Disorders are always remain difficult because of many similarities. Sometimes, the intermediate diagnose disease are also called as Schizoaffective Disorder.

Related Bipolar Disorders ConferencesBipolar Disorders Congress Bipolar Disorders Events | Meetings on Bipolar Disorders

2nd International Conference on Sleep Disorders and Medicine, November 28-30, 2016 Atlanta, USA, 2nd International Conference on Parkinson’s Disease and  Movement Disorders, December 05-07, 2016 Phoenix, USA, 2nd International Conference on Central Nervous System Disorders and Therapeutics, December 05-07, 2016 Dubai, UAE, 4 International Conference on Vascular Dementia on June 30 - July 02, 2016 Valencia, Spain, International Conference and Exhibition on Dual Diagnosis, July 18-19, 2016 Chicago, Illinois, USA, International Conference on Neuro Oncology and Brain Tumor, July 21-22, 2016 Brisbane, Australia,10th International Neuroscience and Biological Psychiatry ISBS Regional on December 01- 03, 2016, at Rio de Janeiro, Brazil, Havana 2016 - 18th World Congress of Psychophysiology on August 31, 2016 - 04 September 2016 at Havana, Cuba, 9th International Regional Neuroscience and Biological Psychiatry Conference "Stress and Behaviour" (China and South East Asia) on October 27-29, 2016 at Zhanjiang, China, International Neuroscience and Biological Psychiatry ISBS Symposium "Translational Neuroscience Of Stress" on November 10 - 11, 2016 at San Diego, USA, Society for Neuroscience 2016 Annual Meeting on November 12 - 16, 2016 at San Diego, USA, 2016 Sleep Summit on November 22 - 24, 2016 at London, United Kingdom, Disabled American Veteransand  Disabled Sports USA, Fabry Supportand  Information Groupand  Facioscapulohumeral Muscular Dystrophy , Children's Brain Disease Foundation and  Children's Brain Tumor Foundation, Dravet Syndrome Foundation and  Dysautonomia Foundation, Dysautonomia Youth Network of America, Inc. and Dystonia Medical Research Foundation

Track 9: Comorbidity of Bipolar Disorders

The epidemiological surveys and studies of the other mental disorders for the comorbidity with bipolar disorders pointed out that the bipolar disorder are often diagnosed coexist with other mental disorders like substance abuse, eating, addictions and personality disorders and anxiety disorder. Numbers of journals has been reported about the evidence of genetic overlapping and influences on schizophrenia with Bipolar Disorders. It has been reported that, twins shows a genetic correlation between the disorders with high ratios. Adopted do not shows disorder correlations like twins. Thus, studies concluded; twins shared with same short of mental disorders and other manic episodes like schizophrenic because of its shared and influenced genes.

Related Bipolar Disorders ConferencesBipolar Disorders Congress Bipolar Disorders Events | Meetings on Bipolar Disorders

International Conference on Neurorehabilitation July 21-22, 2016 Brisbane, Australia, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2016 Vienna, Austria, International Conference on Neuroimaging and Interventional Radiology August 22-23, 2016 Vienna, Austria, 2nd International Conference on Autism, September 15-16, 2016 Phoenix, Arizona,USA, 2nd International Conference on Brain Disorders and Therapeutics, October 26-28, 2016 Chicago, USA, International conference on Bipolar Disorders, Schizophrenia and  Mental Disorders,10th International Neuroscience and Biological Psychiatry ISBS Regional on December 01- 03, 2016, at Rio de Janeiro, Brazil, Havana 2016 - 18th World Congress of Psychophysiology on August 31, 2016 - 04 September 2016 at Havana, Cuba, 9th International Regional Neuroscience and Biological Psychiatry Conference "Stress and Behaviour" (China and South East Asia) on October 27-29, 2016 at Zhanjiang, China, International Neuroscience and Biological Psychiatry ISBS Symposium "Translational Neuroscience Of Stress" on November 10 - 11, 2016 at San Diego, USA, Society for Neuroscience 2016 Annual Meeting on November 12 - 16, 2016 at San Diego, USA, 2016 Sleep Summit on November 22 - 24, 2016 at London, United Kingdom, Alternating Hemiplegia of Childhood Foundation and  Alzheimer’s Drug Discovery Foundation, Benign Essential Blepharospasm, Research Foundation and  Birth Defect Research for Children, Inc, Caregiver Action Netork and  Carter Centers for Brain Research in Holoprosencephaly, Dana Foundation and  Dandy-Walker Alliance, Alzheimer's Association and  Alzheimer's Foundation of America, Blaze Sports America and  Bluefield Project to Cure Frontotemporal Dementia


Track 10: Assessing and Treating for Bipolar Disorders

Assessing of bipolar disorders patients are the important part of treatment with the medication treatment. It is considered as best treatment method for bipolar disorders as because; it is the combination of both assessing and medications. It is unfortunate that many of doctors are void of available and specific treatment for mental disorders. Thus, they commonly treat the metal disorders with one type of medications which causes numbers of side effects. Fortunately researchers have found other ways for the proper treatment of bipolar disorders i.e. Adjunctive therapy and electroconvulsive therapy, Lithium therapy and antidepressant Chrono therapy and social rhythm therapy including non-convulsive and sub convulsive therapeutic methods.

Related Bipolar Disorders ConferencesBipolar Disorders Congress Bipolar Disorders Events | Meetings on Bipolar Disorders

International Conference on Neurorehabilitation July 21-22, 2016 Brisbane, Australia, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2016 Vienna, Austria, International Conference on Neuroimaging and Interventional Radiology August 22-23, 2016 Vienna, Austria, 2nd International Conference on Autism, September 15-16, 2016 Phoenix, Arizona,USA, 2nd International Conference on Brain Disorders and Therapeutics, October 26-28, 2016 Chicago, USA, International conference on Bipolar Disorders, Schizophrenia and  Mental Disorders,10th International Neuroscience and Biological Psychiatry ISBS Regional on December 01- 03, 2016, at Rio de Janeiro, Brazil, Havana 2016 - 18th World Congress of Psychophysiology on August 31, 2016 - 04 September 2016 at Havana, Cuba, 9th International Regional Neuroscience and Biological Psychiatry Conference "Stress and Behaviour" (China and South East Asia) on October 27-29, 2016 at Zhanjiang, China, International Neuroscience and Biological Psychiatry ISBS Symposium "Translational Neuroscience Of Stress" on November 10 - 11, 2016 at San Diego, USA, Society for Neuroscience 2016 Annual Meeting on November 12 - 16, 2016 at San Diego, USA, 2016 Sleep Summit on November 22 - 24, 2016 at London, United Kingdom, Cerebral Palsy Foundation and  CHADD – Children and  Adults with Attention-Deficit/Hyperactivity Disorder, Dana Foundation and  Dandy-Walker Alliance, Fight SMA and  FOCUS Families, Epilepsy Foundation and  Epilepsy Institute, American Association on Health and  Disability and  American Autoimmune Related Diseases Association

 Track 11: Anti-psychosis and Mood Stabilisers for Bipolar Disorders

Drugs for the treatment of bipolar disorders are being manufacture but with the lack of specifications. Commonly, antipsychotic are being used to treat and stabilize psychotic events other psychosis moods. Psychotic moods are commonly the symptoms for many types of mental disorders. Latest drugs called atypical antipsychotic caused least side effects and these are currently being commonly prescribed for bipolar disorders. These drugs stabilize the mood swing effectively with least side as compare to the older antipsychotics but, it still caused side effects.

Related Bipolar Disorders ConferencesBipolar Disorders Congress Bipolar Disorders Events | Meetings on Bipolar Disorders

International Conference on Neurorehabilitation July 21-22, 2016 Brisbane, Australia, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2016 Vienna, Austria, International Conference on Neuroimaging and Interventional Radiology August 22-23, 2016 Vienna, Austria, 2nd International Conference on Autism, September 15-16, 2016 Phoenix, Arizona,USA, 2nd International Conference on Brain Disorders and Therapeutics, October 26-28, 2016 Chicago, USA, International conference on Bipolar Disorders, Schizophrenia and  Mental Disorders,10th International Neuroscience and Biological Psychiatry ISBS Regional on December 01- 03, 2016, at Rio de Janeiro, Brazil, Havana 2016 - 18th World Congress of Psychophysiology on August 31, 2016 - 04 September 2016 at Havana, Cuba, 9th International Regional Neuroscience and Biological Psychiatry Conference "Stress and Behaviour" (China and South East Asia) on October 27-29, 2016 at Zhanjiang, China, International Neuroscience and Biological Psychiatry ISBS Symposium "Translational Neuroscience Of Stress" on November 10 - 11, 2016 at San Diego, USA, Society for Neuroscience 2016 Annual Meeting on November 12 - 16, 2016 at San Diego, USA, 2016 Sleep Summit on November 22 - 24, 2016 at London, United Kingdom, Blaze Sports America and Bluefield Project to Cure Frontotemporal Dementia, Charcot-Marie-Tooth Association and Charlie Foundation for Ketogenic Therapies, Davis Phinney Foundation and Disability Resources, Familial Dysautonomia Hope Foundation and Family Caregiver Alliance/ National Center on Caregiving, Epilepsy Therapy Project and Exceptional Parent Magazine 


Track 12: Genetic and cellular markers in Bipolar Disorders

Bipolar Disorders have been divided into two different categories i.e. Bipolar I and Bipolar II base on its mood events and mania phase. However, effective and exact studies are not yet been properly done on Bipolar Disorders. Genetic studies have been done in various methods to find out the easy therapeutic solutions and cause. The various genetic studies have reported that there are chromosomal similarities and linkage to bipolar disorders in twins. But, there is a lack of study base on meta-analysis of microsatellite markers linkage. Due to mix finding reports by various researchers on genetic association studies of individual persons, there is a lack of proper reports about the cause of bipolar disorders.

Related Bipolar Disorders ConferencesBipolar Disorders Congress | Bipolar Disorders Events | Meetings on Bipolar Disorders

2nd International Conference on Sleep Disorders and Medicine, November 28-30, 2016 Atlanta, USA, 2nd International Conference on Parkinson’s Disease and  Movement Disorders, December 05-07, 2016 Phoenix, USA, 2nd International Conference on Central Nervous System Disorders and Therapeutics, December 05-07, 2016 Dubai, UAE, 4 International Conference on Vascular Dementia on June 30 - July 02, 2016 Valencia, Spain, International Conference and Exhibition on Dual Diagnosis, July 18-19, 2016 Chicago, Illinois, USA, International Conference on Neuro Oncology and Brain Tumor, July 21-22, 2016 Brisbane, Australia, DGNC — Annual Meeting of the German Society of Neurosurgery during June 12 – 15, 2016 at Frankfurt am Main, Germany, 7th International Regional Stress And Behaviour Neuroscience and Biopsychiatry Conference (North America) on June 22 – 24, 2016 at Miami Beach, USA, FENS FORUM 2016 on July 02 – 06, 2016 at Copenhagen, Denmark, The power of mathematics in contemporary neuroscience during July 11 – 15, 2016 at Marseille, France, YOKOHAMA-2016 on July 23 – 24, 2016 at Yokohama, Russia, American Behcet's Disease Associationand  American Brain Coalition, Fibromuscular Dysplasia Society of America and  Fibromyalgia Network, Brain Aneurysm Foundation and  Brain Injury Association of America, Inc., Brain Injury Resource Center and  Brain Trauma Foundation, Chiariand  Syringomyelia Foundation and  Childhood Brain Tumor Foundation

Track 13: Advancement in Research on Bipolar Disorders

New advancement in research is being taking over the older methods of research on bipolar disorders. Researchers are trying to provide evidence based best qualitative methods and quantitative procedures to treat bipolar patients, after that there would be no needing of further treating and diagnosing. Around the globe, researchers are trying to figure out and explore the new techniques and methods to understand emotions and stress of bipolar disorders patients.

Scientist has come across a very longs ways to provide accurate diagnosing methods for bipolar disorders. But, there is still lack of accuracy and precision which often yields side effects and misdiagnosed of bipolar disorders.

Related Bipolar Disorders ConferencesBipolar Disorders Congress Bipolar Disorders Events | Meetings on Bipolar Disorders

International Conference on Neurorehabilitation July 21-22, 2016 Brisbane, Australia, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2016 Vienna, Austria, International Conference on Neuroimaging and Interventional Radiology August 22-23, 2016 Vienna, Austria, 2nd International Conference on Autism, September 15-16, 2016 Phoenix, Arizona,USA, 2nd International Conference on Brain Disorders and Therapeutics, October 26-28, 2016 Chicago, USA, International conference on Bipolar Disorders, Schizophrenia and  Mental Disorders, DGNC — Annual Meeting of the German Society of Neurosurgery during June 12 – 15, 2016 at Frankfurt am Main, Germany, 7th International Regional Stress And Behaviour Neuroscience and Biopsychiatry Conference (North America) on June 22 – 24, 2016 at Miami Beach, USA, FENS FORUM 2016 on July 02 – 06, 2016 at Copenhagen, Denmark, The power of mathematics in contemporary neuroscience during July 11 – 15, 2016 at Marseille, France, YOKOHAMA-2016 on July 23 – 24, 2016 at Yokohama, Russia, Disabled American Veteransand  Disabled Sports USA, Fabry Supportand  Information Groupand  Facioscapulohumeral Muscular Dystrophy , Children's Brain Disease Foundation and  Children's Brain Tumor Foundation, Dravet Syndrome Foundation and  Dysautonomia Foundation, Dysautonomia Youth Network of America, Inc. and Dystonia Medical Research Foundation

Track 14: Case Reports on Bipolar Disorders

The case reports are always been a key which helps to became awareness about things that are happening or happened. Many case reports concluded that bipolar disorders are most affected to the North America. India is with least affected by bipolar disorders. Numbers of journals reported the co-existence of bipolar disorders with other mental disorders and many drugs have been reported to cause severe side effects. Numbers of misdiagnosis and mistreating the bipolar disorders patients, suicides, murders and divorce has been reported because of bipolar disorders. Antidepressant like Prozac has been reported to be discontinued as medicine for bipolar disorders because of its severe side effects and worsening the bipolar disorders patients.

Related Bipolar Disorders ConferencesBipolar Disorders Congress Bipolar Disorders Events | Meetings on Bipolar Disorders

International Conference on Neurorehabilitation July 21-22, 2016 Brisbane, Australia, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2016 Vienna, Austria, International Conference on Neuroimaging and Interventional Radiology August 22-23, 2016 Vienna, Austria, 2nd International Conference on Autism, September 15-16, 2016 Phoenix, Arizona,USA, 2nd International Conference on Brain Disorders and Therapeutics, October 26-28, 2016 Chicago, USA, International conference on Bipolar Disorders, Schizophrenia and  Mental Disorders,10th International Neuroscience and Biological Psychiatry ISBS Regional on December 01- 03, 2016, at Rio de Janeiro, Brazil, Havana 2016 - 18th World Congress of Psychophysiology on August 31, 2016 - 04 September 2016 at Havana, Cuba, 9th International Regional Neuroscience and Biological Psychiatry Conference "Stress and Behaviour" (China and South East Asia) on October 27-29, 2016 at Zhanjiang, China, International Neuroscience and Biological Psychiatry ISBS Symposium "Translational Neuroscience Of Stress" on November 10 - 11, 2016 at San Diego, USA, Society for Neuroscience 2016 Annual Meeting on November 12 - 16, 2016 at San Diego, USA, 2016 Sleep Summit on November 22 - 24, 2016 at London, United Kingdom, , United Kingdom, Alternating Hemiplegia of Childhood Foundation and  Alzheimer’s Drug Discovery Foundation, Benign Essential Blepharospasm, Research Foundation and  Birth Defect Research for Children, Inc, Caregiver Action Netork and  Carter Centers for Brain Research in Holoprosencephaly, Dana Foundation and  Dandy-Walker Alliance, Alzheimer's Association and  Alzheimer's Foundation of America, Blaze Sports America and  Bluefield Project to Cure Frontotemporal Dementia


 

International conference on Bipolar Disorder, Schizophrenia & Mental Disorders is going to be held on October 26- 27, 2016 at Chicago, in USA. Conference Series LLC organizes conference every year all around the world. We make the platform for global networking as it brings together renowned speakers and scientists across the world to a most exciting and memorable scientific events, filled with much enlightening interactive sessions, world class exhibitions and poster presentations. We cordially welcome you to this International conference on Bipolar Disorders, Schizophrenia and Mental Disorders.

The conference Bipolar Disorder will be organized around the theme “Innovative Research and Therapeutic Approaches towards the Bipolar Disorder, Schizophrenia & Mental Disorders”. Aim of this conference is to stimulate new ideas to deal with the treatment and modifies old ideas of treatment that will be beneficial across the spectrum of Bipolar disorder.

Every year, about 42.5 million American adults (or 18.2 percent of the total adult population in the United States) suffer from some mental illness; enduring conditions such as depression, bipolar disorder or schizophrenia. The Substance Abuse and Mental Health Services Administration (SAMHSA), also indicate that approximately 9.3 million adults, or about 4 percent of those Americans ages 18 and up, experience “serious mental illness” – that is, their condition impedes day-to-day activities, such as going to work. The United States has the highest lifetime rate of bipolar disorder at 4.4% compare to the other developed countries. The rising rate of Mental Disorders, less numbers of research institution and medical academics became a global concern for the awareness about the Bipolar Disorders, Schizophrenia and other Mental Disorders.

The World Economic Forum, recognizing that chronic non-communicable diseases would be the largest cost drivers in health care in the 21st century, asked a group of health economists to estimate global costs and project costs to 2030.Their estimate based on 2010 data showed mental disorders as the largest cost driver at $2.5 trillion in global costs in 2010 and projected costs of $6.0 trillion by 2030. The costs for mental disorders were greater than the costs of diabetes, respiratory disorders, and cancer combined.

The Substance Abuse and Mental Health Administration estimated that the U.S. national expenditure for mental health care was $147 billion in 2009. Combining this figure with updated projections of lost earnings and public disability insurance payments associated with mental illness, an estimate for the financial cost of mental disorders was at least $467 billion in the U.S. in 2012.

The Bipolar Disorders 2016 endeavours to covers all array of vitally on Innovative research and therapeutic approaches towards the Bipolar Disorders. Your research findings and experience on Bipolar disorders, Schizophrenia and Mental Disorders will provide an opportunity to discuss and respond to a series of questions about the status of advanced Mental Disorders research.

The conference’s goal is to provide a broad discussion on current advancement in the field of therapeutics and research on Bipolar Disorders, Schizophrenia, Mental Disorders and other Neurological comorbidity disorders that will coherently help in providing better future more..

Why to attend the conference?

International Conference on Bipolar Disorder, Schizophrenia and Mental Disordes aims to bring together worldwide distinguished academics in the field of Neurophysiologists, Neuropsychiatrists, Geneticist, Neuroscience, Medical Neurology, Brain researchers, Public Health professionals, Scientists, Academic scientists, Industry researchers, Scholars to exchange about state of the art Research and Technologies and to bring discoveries of mental patients. The curiosity of any researchers has to understand the current state of research on Mental Disorders and the challenges to future discovery. Attending International conference is for the Professional Development.

The aim of the Conference is to provide a platform to academicians and practitioners from multiple disciplines to debate and deliberate on social change that is encompassed by innovation and technology.

Target Audience:

Scientist, Directors, Psychiatrist, Head of department, Professors and Students from Academia in Bipolar Disorders, Schizophrenia and Mental Disorders research.

Target Audience:

  • Scientist         45%
  • Academia       35%
  • Industry          10%
  • Others             10%

 

Dear colleagues!
As a Member of the Organizing Committee, I cordially welcome all you eminent colleagues to this important conference! Bipolar disorders are still a provoking complexity that causes severe impact on individuals, families and societies, worldwide. When it becomes aggravated by another severe complexity, suicidal propensity, it is even more difficult to understand. However, possibly, the innovative and emerging branch of science of orienting hyporeactivity and vulnerability to suicide may offer new perspectives to this complexity. 
The objectively measurable neuropsychological dysfunction that causes hyporeactivity to the everyday reality is strongly related to vulnerability to suicide in depression, perhaps particularly in bimodal disorders. My task today is to inform and enthuse researchers in neuropsychology, neurophysiology, psychology and psychiatry to further advance the field, theoretically and clinically, for deeper understanding of bimodal disorders and vulnerability to suicide and for clinical application of that knowledge for more effective suicide prevention. Further, my task is to learn important facts and theories from you, my dear colleagues, in listening to your presentations and argumentation in this and close topics.



Dr. Lars H Thorell
Director of Research
Emotra AB, Gothenbur and Linkoping,
Linkoping University, Sweden.

The conference Bipolar disorder, Schizophrenia & Mental Disorders will be organized around the theme “Innovative Research and Therapeutic Approaches towards the Bipolar Disorder, Schizophrenia and Mental Disorders”.

Our whole committee members are headed up for dazzling and enlightening scientific conference which includes lectures, speakers, symposia, workshops on different topics, poster presentations and various programs for participants from all around the world. We take immense pleasure inviting you to join us at Bipolar Disorder 2016. You can have a world class experience with the learned persons from all around the world. All members of Bipolar Disorder-2016 organizing committee look forward in meeting you in Chicago, USA.

Importance and scope

Many family-genetic studies of neurobehavioral disorders have been or are currently being conducted by groups of investigators who separately analyse their data.  Scientific advancement and ultimate success in identifying disease susceptibility loci likely will require integration of data to obtain samples of sufficient size that have high power for the detection of susceptibility loci of small relative effect.

               People or associations, associate with the research of Bipolar Disorder faces a number of challenges related to fellowship training, particularly in the areas of supply and recruitment, program structure and content and financial support. Effectively addressing these challenges requires a reconsideration of the fundamental goals and needs of Bipolar disorder, Schizophrenia and other related Mental Disorders treatment training as well as targeted action to reinvigorate the field. Our organization seeks to promote comprehensive assessment of psychopathology, neuropsychiatry and Neurosurgery including the developmental assessment of Mental Disorders, and the application of high-throughput genotyping efforts, interdisciplinary models for the treatment and research on Bipolar Disorder , Schizophrenia and other Mental Disorders through the exchange of ideas, techniques and collaboration among the scientific organization, scientist and researcher.

Why in Chicago, USA?

Chicago has the third largest gross metropolitan product in the United States—about $547 billion according to 2012 estimates. Chicago has GDP of $ 557,745 million in 2014. Only the urban agglomerations of New York City and Los Angeles are larger. The city has also been rated as having the most balanced economy in the United States, due to its high level of diversification. Chicago was named the fourth most important business center in the world in the MasterCard Worldwide Centers of Commerce Index. Additionally, the Chicago metropolitan area recorded the greatest number of new or expanded corporate facilities in the United States for calendar year 2014. The Chicago metropolitan area has the third largest science and engineering work force of any metropolitan area in the nation. In 2009 Chicago placed 9th on the UBS list of the world's richest cities. Chicago was the base of commercial operations for industrialists John Crerar, John Whitfield Bunn, Richard Teller Crane, Marshall Field, John Farwell, Julius Rosenwald and many other commercial visionaries who laid the foundation for Midwestern and global industry.

Chicago is a major world financial center, with the second largest central business district in the United States. The city is the headquarters of the Federal Reserve Bank of Chicago (the Seventh District of the Federal Reserve). The city has major financial and futures exchanges, including the Chicago Stock Exchange, the Chicago Board Options Exchange (CBOE), and the Chicago Mercantile Exchange (the "Merc"), which is owned, along with the Chicago Board of Trade (CBOT) by Chicago's CME Group. The CME Group, in addition, owns the New York Mercantile Exchange (NYMEX), the Commodities Exchange Inc. (COMEX) and the Dow Jones Indexes. Perhaps due to the influence of the Chicago school of economics, the city also has markets trading unusual contracts such as emissions (on the Chicago Climate Exchange) and equity style indices (on the U.S. Futures Exchange). Chase Bank has its commercial and retail banking headquarters in Chicago's Chase Tower.

The city and its surrounding metropolitan area contain the third largest labor pool in the United States with about 4.48 million workers, as of 2014.In addition, the state of Illinois is home to 66 Fortune 1000 companies, including those in Chicago. The city of Chicago also hosts 12 Fortune Global 500 companies and 17 Financial Times 500 companies. The city claims one Dow 30 company: aerospace giant Boeing, which moved its headquarters from Seattle to the Chicago Loop in 2001. Two more Dow 30 companies, Kraft Foods and McDonald's are in the Chicago suburbs, as are Sears Holdings Corporation and the technology spin-offs of Motorola. The headquarters of United Continental Holdings, are in the United Building and its operations center and its United Airlines subsidiary are in the Willis Tower in Chicago.

Manufacturing, printing, publishing and food processing also play major roles in the city's economy. Several medical products and services companies are headquartered in the Chicago area, including Baxter International, Boeing, Abbott Laboratories, and the Healthcare Financial Services division of General Electric. In addition to Boeing, which located its headquarters in Chicago in 2001, and United Airlines in 2011, GE Transportation moved its offices to the city in 2013, as did ThyssenKrupp North America, and agriculture giant Archer Daniels Midland. Moreover, the construction of the Illinois and Michigan Canal, which helped move goods from the Great Lakes south on the Mississippi River, and of the railroads in the 19th century made the city a major transportation center in the United States. In the 1840s, Chicago became a major grain port, and in the 1850s and 1860s Chicago's pork and beef industry expanded. As the major meat companies grew in Chicago many, such as Armour and Company, created global enterprises. Though the meatpacking industry currently plays a lesser role in the city's economy, Chicago continues to be a major transportation and distribution center. Lured by a combination of large business customers, federal research dollars, and a large hiring pool fed by the area's universities, Chicago is also the site of a growing number of web startup companies like CareerBuilder, Orbitz, 37signals, Groupon, Feedburner, and NowSecure.

Chicago has been a hub of the Retail sector since its early development, with Montgomery Ward, Sears, and Marshall Field's. Today the Chicago metropolitan area is the headquarters of several retailers, including Walgreens, Sears, Ace Hardware, Claire's, ULTA Beauty and Crate & Barrel.

Late in the 19th century, Chicago was part of the bicycle craze, with the Western Wheel Company, which introduced stamping to the production process and significantly reduced costs,while early in the 20th century, the city was part of the automobile revolution, hosting the Brass Era car builder Bugmobile, which was founded there in 1907. Chicago was also the site of the Schwinn Bicycle Company.

Chicago is a major world convention destination. The city's main convention center is McCormick Place. With its four interconnected buildings, it is the largest convention center in the nation and third largest in the world.Chicago also ranks third in the U.S. (behind Las Vegas and Orlando) in number of conventions hosted annually.

Number of world class companies and research centre are providing following medicines in America, like;

  • Lithium (Lithobid) - Solvay Company
  • Valproate (Depakote) - Abbott Laboratories
  • Bupropion (Wellbutrin) - Glaxo-Smith Kline
  • Paroxetine (Paxil) - Glaxo-Smith Kline
  • Lamotrigine (Lamictal) - Glaxo-Smith Kline
  • Risperidone (Risperdal) - Janssen Pharmaceuticals
  • Omega 3 (DHA) - Martek Biosciences



List of Medical research centres in USA.
 

  • Academy of Neuroscience for Architecture
  • AIDS Research Alliance
  • Alfred E. Mann Institute for Biomedical Engineering
  • American College of Rheumatology Research and Education Foundation
  • American College of Surgeons Oncology Group
  • American Roentgen Ray Society
  • Athinoula A. Martinos Center for Biomedical Imaging
  •  
  • Dana–Farber Cancer Institute
  • Dana–Farber/Harvard Cancer Center
  • Duke Cancer Institute
  • Duke University Human Vaccine Institute
  •  
  • Eastern Cooperative Oncology Group
  • Emerging Pathogens Institute
  • Epilepsy Foundation of Florida University
  • Eppley Institute for Research in Cancer and Allied Diseases
     
  • Fred Hutchinson Cancer Research Center
  •  
  • Galveston National Laboratory
  • Ganogen Research Institute
  • Genetics Society of America
  • George Washington University School of Medicine & Health Sciences
  • Gladstone Institutes
  • Gottlieb Institute
  •  
  • Hauptman-Woodward Medical Research Institute
  • Henry M. Jackson Foundation for the Advancement of Military Medicine
  • Hormel Institute
  • House Ear Institute
  • Howard Hughes Medical Institute
  • Huntington Medical Research Institutes
  • Huntsman Cancer Foundation
  • Huntsman Cancer Institute
  •  
  • The Biodesign Institute
  • Torrey Pines Institute for Molecular Studies
  • Tower Cancer Research Foundation
  •  
  • University of Central Florida College of Medicine
  • University of South Florida College of Medicine
  • USC Norris Comprehensive Cancer Center
  • USF Health Byrd Alzheimer's Institute
  • Beckman Research Institute
  • Bone Disease Program of Texas
  • The Bonnie J. Addario a Breath Away from the Cure Foundation
  • Boonshoft School of Medicine
  • Brain Injury Research Institute
  • Buck Institute for Research on Aging
  •  
  • Institute for Health Metrics and Evaluation
  • Institute of Biosciences and Technology
  • Institute of Gerontology
  •  
  • Jackson Laboratory
  • John Paul II Medical Research Institute
  • Kenneth S. Warren Institute
  •  
  • La Jolla Institute for Allergy and Immunology
  • Lahey Hospital & Medical Center
  • Lieber Institute for Brain Development
  • Linus Pauling Institute
  • Lovelace Respiratory Research Institute
  •  
  • Markey Cancer Center
  • Memorial Sloan Kettering Cancer Center
  • The Mind Research Network
  • H. Lee Moffitt Cancer Center & Research Institute
  • Myelin Repair Foundation
  •  
  • National Center for Biotechnology Information
  • National Center for Integrative Biomedical Informatics
  • National Comprehensive Cancer Network
  • National Space Biomedical Research Institute
  • National Wilms Tumor Study Group
  • The Neurosciences Institute
  • Nevada Cancer Institute
  • New York Blood Center
  • Nicholas Institute of Sports Medicine and Athletic Trauma
  • Norris Cotton Cancer Center
  •  
  • Van Andel Institute
  •  
  • Winship Cancer Institute
  •  
  • Yale Cancer Center
  • Yerkes National Primate Research Center
  •  
  • Zilkha Neurogenetic Institute
     
  • UW Carbone Cancer Center
  • California Institute for Regenerative Medicine
  • California National Primate Research Center
  • Cancer and Leukemia Group B
  • Cancer Therapy & Research Center
  • Center for Biologics Evaluation and Research
  • Center for Cell and Gene Therapy
  • Center for Disease Dynamics, Economics & Policy
  • Center for Infectious Disease Research
  • Center for Neural Science
  • Center for the Study of Traumatic Encephalopathy
  • Centers for Disease Control and Prevention
  • The Christopher and Dana Reeve Paralysis Resource Center
  • City of Hope National Medical Center
  • Cleveland Clinic Lerner Research Institute
  • Collaborative Study On The Genetics of Alcoholism
  • Community Programs for Clinical Research on AIDS
  • CONRAD (organization)
  • Coriell Institute for Medical Research
  •  
  • Pacific Northwest Diabetes Research Institute
  • Patient-Centered Outcomes Research Institute
  • Pediatric Cancer Research Foundation
  • Pritzker Neuropsychiatric Disorders Research Consortium
  •  
  • Office of Cancer Complementary and Alternative Medicine
  •  
  • Quality Assurance Review Center
  •  
  • Rice Center for Neuroengineering
  • Roswell Park Cancer Institute
  •  
  • St. Jude Children's Research Hospital
  • Salk Institute for Biological Studies
  • Sanford Burnham Prebys Medical Discovery Institute
  • Sarah Cannon Research Institute
  • Scripps Research Institute
  • Seattle Children's Research Institute
  • Semel Institute for Neuroscience and Human Behavior
  • SWOG



International conference on Bipolar Disorder, Schizophrenia and Mental Disorders at Chicago, USA.

International Conference on ‘Bipolar Disorders, Schizophrenia and Mental Disorders’ is a unique forum to bring together worldwide distinguished academicians, researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies.

Aim of this conference is to stimulate new ideas to deal with the treatment and modifies old ideas of treatment that will be beneficial across the spectrum of Bipolar disorder.

Conference Highlights:

·         Bipolar Disorder

·         Understanding Bipolar Disorders

·         Progression in Treatment of Bipolar Disorders

·         Prevention of Bipolar Disorder

·         Diagnosis and Neuroimaging of Bipolar Disorders

·         Comorbidity of Bipolar Disorders

·         Mechanisms and prevention of non-central lithium-induced side effects

·         Assessing and Treating for Bipolar Disorders

·         Anti psychosis and Mood Stabilisers for Bipolar Disorders

·         Genetic and cellular markers in Bipolar Disorders

·         Advancement in Research on Bipolar Disorders

·         Case reports on Bipolar Disorders

·         Schizophrenia

·         Mental Disorders

·         Entrepreneurs Meets for Bipolar Disorders

 

There about 22 research centres in North America for the research and treatment of Bipolar Disorder

Over the course of the seven years of the study, 22 research centers around the North American countries, enrolled and treated participants. Thirteen centers participated for the majority of the active project, and participants from these centers comprise 90 percent of the total number enrolled.

  • Baylor College of Medicine; Houston, TX Principal Investigator, Lauren B. Marangell, MD
  • Case Western Reserve University; Cleveland, OH Principal Investigator, Joseph R. Calabrese, MD
  • University of Colorado Health Sciences Center; Denver, CO Principal Investigator, Michael Allen, MD
  • University of Louisville School of Medicine; Louisville, KY Principal Investigator, Rif El-Mallakh, MD
  • Massachusetts General Hospital and Harvard School of Medicine; Boston, MA Principal Investigator, Andrew A. Nierenberg, MD
  • University of Massachusetts Medical School; Worcester, MA Principal Investigator, Jayendra Patel, MD
  • University of Missouri School of Medicine; Kansas City, MO Principal Investigator, Kemal Sagduyu, MD
  • University of Oklahoma College of Medicine - Tulsa; Tulsa, OK Principal Investigator, Mark D. Fossey, MD
  • University of Pennsylvania School of Medicine and Medical Center; Philadelphia, PA Principal Investigator, Laszlo Gyulai, MD
  • University of Pittsburgh Western Psychiatric Institute and Clinic; Pittsburgh, PA Principal Investigator, Michael E. Thase, MD
  • Portland Veteran’s Administration Medical Center; Portland, OR Principal Investigator, Peter Hauser, MD
  • Stanford University School of Medicine; Stanford, CA Principal Investigator, Terence A. Ketter, MD
  • University of Texas Health Science Center at San Antonio, San Antonio, TX Principal Investigator, Charles Bowden, MD

Additional centers involved in Bipolar disorder were: Howard University, Washington DC; Rush-Presbyterian St. Luke’s Medical Center, Chicago, IL; State University of New York at Buffalo, Buffalo, NY; Weill Medical College of Cornell University and New York Presbyterian Hospital, NY, NY; New York University School of Medicine, NY, NY; University of California San Diego, La Jolla, CA; University of Arizona, Tucson, AZ; and Medical University of South Carolina, Charleston, SC.

Major Associations around the Globe

  • American psychological association
  • National association of school psychologists
  • European Association for Forensic Child and Adolescent Psychiatry, Psychology and other involved Professions
  • Association of Child Psychologists in Private Practice
  • European Association for Developmental Psychology
  • The German Society of Pediatrics and Adolescent Medicine

Target Audience:

Scientist, Directors, Psychiatrist, Head of department, Professors and Students from Academia in the research of Bipolar Disorder.

Target Audience:

  • Scientist         45%
  • Academia        35%
  • Industry          10%
  • Others             10%

  • Blue color = Scientist
  • Red color = Academia
  • Green = Industries
  • Navy Blue = Others

 

Latest market Value of the medicine for Mental Disorders

Here is the list. The price listed is for one single pill.

First Generation Antipsychotics:

Brand Names

Quantity

Prices per pill

Chlorpromazine (Thorazine)

100mg

$1.41

Thiothixene (Navane)

5mg

$0.29

Thioridazine (Mellaril)

100mg

$0.20

Trifluoperazine (Stelazine)

5mg

$0.38

Perphenazine (Trilafon)

8mg

$1.02

Fluphenazine (Prolixin)

5mg

$0.09

Haloperidol (Haldol)

2mg

$0.10

 

5mg

$0.11

 

10mg

$0.66

 

Second Generation Antipsychotics

Brand Name

Quantity

Price per pill

Risperidone (Risperdal)

1mg

$0.10

 

2mg

$0.13

 

3mg

$0.15

 

4mg

$0.17

Olanzapine (Zyprexa)

10mg

$0.34

 

15mg

$0.52

 

20mg

$0.69

Quetiapine (Seroquel)

100mg

$0.23

 

200mg

$0.35

 

300mg

$0.45

 

400mg

$0.64

Abilify

20mg

$26.60

Geodon

60mg

$9.89

Invega

6mg

$17.13

Fanapt

8mg

$10.31

Clozaril

100mg

$0.92

 

Major advancement in treatment of Bipolar Disorder

Short-term treatment of bipolar depression

Until a few years ago, there had been a dearth of controlled trials on bipolar depression, and those undertaken involved only small samples. Traditionally, the major treatments for bipolar depression have been antidepressants (E2) (or occasionally lithium [E2]), with the major disadvantage being the propensity for antidepressants to induce either manic episodes or a rapid-cycling pattern of illness.

In 1999, Calabrese et al reported that the anticonvulsant lamotrigine, taken alone, was more effective than placebo. Subsequent studies (discussed below) have shown that lamotrigine also prevents recurrence of bipolar depression (E2). Lamotrigine does not appear to be effective in treating unipolar depression. The limiting clinical features of lamotrigine are the development of rash (Stevens–Johnson syndrome may occur) and the related necessity for slow-dose titration.

The other new agent of interest for treating bipolar depression is olanzapine, particularly in combination with the selective serotonin reuptake inhibitor fluoxetine (E2). Tohen et al. reported that olanzapine was more effective than placebo for treating bipolar I depression (E2), although the benefit was not profound. The more dramatic finding of their study was the high response rate (56%) among those receiving the combination treatment compared with those receiving olanzapine only (39%) or placebo (30%). Although this is just one study whose findings clearly require replication, it is nonetheless of significant import.

Pharmacological treatments

Three agents (lithium [E1], lamotrigine [E2] and olanzapine [E2]) have now been confirmed to be effective for maintenance treatment.

The greatest weight of evidence is for lithium, with a Cochrane meta-analysis confirming its prophylactic activity. It is also worth noting that the prophylactic benefit of lithium has been confirmed by its efficacy when employed as an active comparator in the lamotrigine and olanzapine trials. In fact, its benefit may have been underestimated in those trials, as its overall efficacy was clear, irrespective of the fact that some participants were probably lithium non-responders. Lithium has also been reported to reduce suicide rates independently of its prophylactic capacity. The mechanism of this action is unknown. There has also been much interest in the potential clinical ramifications of laboratory studies indicating that lithium has neuroprotective properties.

Perhaps the most novel finding in the prevention of bipolar disorder relapse has arisen from two 18-month RCTs comparing lamotrigine, lithium and placebo in patients with bipolar I disorder. Both studies found lamotrigine to be more effective than placebo in preventing depressive relapse, with a limited efficacy against mania that was only demonstrable in analyses of pooled data from both studies. In these trials, lithium was, conversely, more effective than placebo in preventing manic relapse and less effective against depression (again, only apparent in the pooled data). These findings suggest that the combination of lithium and lamotrigine may be particularly advantageous in long-term treatment, although this is yet to be confirmed.

Olanzapine is also an effective agent in prophylaxis, preventing both manic and depressive relapses. This needs to be balanced against accumulating evidence that atypical antipsychotics such as olanzapine increase the likelihood of diabetes and hyperlipidaemia.

Recent advancement in drugs for Bipolar disorder in market

BUDAPEST--Richter Gedeon Nyrt, (RICHTER.BU) and Forest Laboratories Inc. FRX, -0.64% on Monday announced positive phase IIb topline results for Cariprazine for the treatment of Bipolar Depression.

Stem cell research has allowed the postmortem examination of neurons from those diagnosed with schizophrenia.  This research, originally published in Nature Outlook, and reported in the Irish Times in April 2011, revealed that 600 genes appeared to malfunction in people with schizophrenia.   Individual neurons can be examined for their response to anti-psychotic drugs, raising hopes for more effective treatment options.

In February, 2011, Jonathan Sebat, Ph.D., assistant professor of psychiatry and cellular and molecular medicine at the University of California, San Diego School of Medicine, and his colleagues, published research identifying a gene which holds particular promise in the treatment of schizophrenia. According to Dr. Sebat’s research, Vasoactive Intestinal Peptide Receptor 2 or VIPR2 is much more likely to be found in those with schizophrenia. Because VIPR2 responds to synthetic peptides, already available, targeting this gene is a promising treatment strategy.

Cariprazine shows positive result in treatment of bipolar depression and major depressive disorder.

Its cost is $3.10/pill.

Major advancement in treatment of Schizophrenia

The treatment of schizophrenia was revolutionized with the introduction of chlorpromaeine in

1952. The defectiveness of chlorpromazine in controlling psychotic symptoms lead to the dopamine hypothesis of schizophrenia, which revolutionized our conceptualization of this illness. Since that time, numerous typical antipsychotic drugs have been developed for the treatment of schizophrenia. However, the introduction of clozapine in 1990 began a new era in the pharmacologic management of schizophrenia. Clozapine, an atypical antipsychotic drug, is effective in controlling the positive symptoms of schizophrenia in a large number of otherwise treatment-resistant patients, and also improves the negative symptoms qf the illness in marry patients. Clozapine is classified as an atypical antipsychotic drug because it has little potential for causing extra pyramidal side effects, and its effects on dopaminergic and serotonergic neurotransmitter systems are unique compared with those of typical antipsychotic medications. The effectiveness of clozapine and the explosion of research

in neuroscience has led to the investigation off neurotransmitter systems other than dopamine as important in developing pharmacologic strategies for the treatment of schizophrenia.

Now in adavancing in treatment scientist are going more specific and effective target for the treatment of Schizophrenia by genes research, targeted medications.


Genes Research, Targeted Medications for Schizophrenia:

This comes after Richter and Forest announced positive phase IIb topline results for Cariprazine as adjunctive therapy in the treatment of Major Depressive Disorder on March 21.

The trial consisted of four treatment groups: Cariprazine 0.75 milligram per day, 1.5 mg/day, 3.0 mg/day, and placebo. Statistically significant improvements were observed in the Cariprazine 1.5 mg/day group relative to placebo at six weeks for the primary endpoint, the Montgomery-Asberg Depression Rating Scale (MADRS) total score and the key secondary endpoint, the Clinical Global Impressions - Severity (CGI-S) score.


Market Value for the Mental illness in America

The US Mental Health and Substance Abuse Services industry includes over 17,000 facilities with combined annual revenue of approximately $50 billion.

Including ancillary services, broader industry revenues represent over $300 billion combined.

Mental health and substance abuse market has grown at a 2.1% CAGR from 2008 to 2014E and is expected to grow at a 2.8% CAGR from 2014E to 2018P.

Demand for mental health services has reached an all-time high and continues to grow, while the supply of hospital beds dedicated to mental health patients has steadily declined.

•           13.6% decrease in number of public psychiatric beds from 2000 to 2011

•           Supply / demand disconnect has resulted in shorter stays, growth in outpatient / community-based services, and an increased prevalence of mental illness among prison and homeless populations. US mental health industry remains highly fragmented, continues to incorporate ACA changes, and is expected to remain dynamic.


Large and Growing Industries accompanied by;


 

The mental health-care system in the United States is a multibillion-dollar industry that is still not big enough to serve all those who need it. Costs are a big barrier to treatments -- but so are attitudes about mental health. New laws might change access to mental health, although significant barriers still remain. Here's a look at what we invest in the mental health-care system, what that buys us and where gaps in coverage remain.

The United States spends $113 billion on mental health treatment. That works out to about 5.6 percent of the national health-care spending, according to a 2011 paper in the journal Health Affairs.

This puts us in the same range as other developed nations including Australia and Italy, according to the World Health Organization. Egypt leads the group of countries they surveyed, spending 9 percent of its health budget on mental health treatment.



Mental health care is pricey, with 45 percent of the untreated citing cost as a barrier. A quarter of the 15.7 million Americans who received mental health care listed themselves as the main payer for the services, according to one survey that looked at those services from 2005 to 2009. The majority of those who did seek outpatient treatment had out-of-pocket costs between $100 and $5,000.




Recent federal legislation requires more expansive insurance coverage for mental health services. The Mental Health Parity and Addiction Act of 2008 applies to large, employer-sponsored insurance plans. It bars insurers from putting up financial barriers to mental health care that are greater than those created for physical treatments. While there was some concern that the new requirements would lead employers to drop mental health coverage altogether, a poll by the Kaiser Family Foundation found only 2 percent did so.

The Affordable Care Act creates more mental health mandates, by requiring all insurers who sell on the exchanges to include such treatments in their benefit packages.
 

Total conferences on Bipolar Disorder till date.

All the 11 nations are affected by this disorder. The United States has the highest lifetime rate of bipolar disorder at 4.4%. Brazil has high affected rate of this disorder in South America like USA in North America. Brazil has less institution and research centre for the Bipolar Disorder, to its affected ratio, as compare to the other developed countries. Its rising rate and less of institution and research centres became a global concern for the awareness about the particular disorder.

As per available reports about 222 journals, 39 Conferences and workshops are presently dedicated exclusively to bipolar disorder and about 10718 articles are being published on the current trends in bipolar disorder. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to bipolar disorder are being carried out. As reported in the above mentioned 10718 articles, bipolar disorder is also called as manic-depressive illness, bipolar affective disorder or affective psychosis. It is a mental illness which is characterized by periods of depression and periods of elevated mood. Elevated mood is known as hypomania or mania depending on the severity.

 

Euro Psychiatry Summit-2015

Euro Psychiatry Summit-2015 Report

OMICS International hosted Euro Global Summit and Medicare Expo on Psychiatry during July 20-22, 2015 at Barcelona, Spain based on the theme “Global research and therapeutic approaches towards psychiatry”.

Firstly we must thank you for trusting us and participating at Euro Psychiatry Summit-2015. Active participation and generous response was received from the Organizing Committee Members, scientists, researchers, as well as experts from Non-government organizations, and students from diverse groups who made this conference as one of the most successful and productive events in 2015 from OMICS Group.

The conference was marked with several workshops, multiple sessions, Keynote presentations, panel discussions and Poster sessions. We received active participation from scientists, young and brilliant researchers, business delegates and talented student communities representing more than 35 countries, who have driven this event into the path of success.   

The conference was initiated with a warm welcome note and the Book Launch from Honorable guests and the Keynote forum. The proceedings went through interactive sessions and panel discussions headed by Dr. Rivka A Edery, M.S.W. L.C.S.W, and Dr. Giampaolo Perna, Hermanas Hospitalarias, Italy honorable Moderators for the conference.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following Speakers were highlighted as Keynote speakers:

Jouko Miettunen, University of Oulu, Finland

Giampaolo Perna, Hermanas Hospitalarias, Italy

Thomas E Schlaepfer, University Hospital Bonn, Germany

Charles B Nemeroff, University of Miami, USA

Guillem Feixas Viaplana, University of Barcelona, Spain

Series of workshops and symposiums includes expert presentation by Dr. Charles B Nemeroff, Director of Center of Ageing, University of Miami, USA on “Personalized Medicine in Psychiatry: A Look to the Future” and “Managing “Treatment resistant” Schizophrenia: Pharmacological, Cognitive-behavioral and m-Health Solutions” by Dr. Jouko Miettunen, University of Oulu, Finland.

OMICS Group has taken the privilege of felicitating Euro Psychiatry 2015 Organizing Committee, Keynote Speakers who supported for the success of this event. OMICS Group, on behalf of the Organizing Committee congratulates the Best Poster awardees for their outstanding performance in the field of Psychiatry and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavours.   

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance towards the success of Euro Psychiatry 2015.

Jouko Miettunen, University of Oulu, Finland

Giampaolo Perna, Hermanas Hospitalarias, Italy

Thomas E Schlaepfer, University Hospital Bonn, Germany

Charles B Nemeroff, University of Miami, USA

Guillem Feixas Viaplana, University of Barcelona, Spain

Rocco de Fillipes, Istituto di Psicopatologia, Italy

Ivanka Zivcic Becirevic, University of Rijeka, Croatia

Jesus Garcia Martinez, University of Seville, Spain

With the unique feedbacks from the conference, OMICS Group would like to announce the commencement of the International Conference on Bipolar Disorders on August 22-23, 2016 at Sao Paulo, Brazil. With the support and contribution of the Organizing Committee Members, we successfully hosted the event at the conference venue. We look forward to see your benign presence with active contribution and support to make this event successful once more.

http://www.conferenceseries.com/Past_Reports/Euro-Psychiatry-Summit-2015-past

For more details please Visit: http://bipolar-disorders.conferenceseries.com/

 

 


Past Reports  Gallery  

Neuro-2014

The 3rd International Conference & Exhibition on Neurology and Therapeutics organized by OMICS Group International was successfully held at Hilton Philadelphia Airport, Philadelphia, USA during September 08-10, 2014. The conference was organized with the theme “Novel Therapies in Neurosciences and Neurological Disorders"

The conference was marked with the presence of renowned scientists, talented young researchers, students and business delegates representing more than 20 different countries ultimately driving the event into the path of success.

OMICS Group also took the privilege of felicitating Neurology-2014 Organizing Committee, Editorial Board Members of Journal of Neurology & Neurophysiology , Journal of Brain Disorders & Therapy, Journal of Neurological Disorders and Autism- Open Access, Keynote Speakers,  Chair and Co-Chairs whose support led the conference into the path of excellence.

We are also obliged to various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums.

OMICS Group would like to convey a warm gratitude to all the Honorable guests of Neurology-2014. The highlights of the conference were its educative and effectual keynote lectures by:

Simon Kaja, University of Missouri, USA

James Nussbaum, ProHealth & Fitness PT OT, USA

Marie Trad, Quintiles, France

Jacqueline Sidman, The Sidman Institute, USA

All the above mentioned keynote speakers gave their energetic and fruitful contributions at Neurology-2014All the keynote sessions, speaker sessions, Special session,workshop, symposium, and student poster presentations focused on the specific theme of the conference “Novel Therapies in Neurosciences and Neurological Disorders” The theme of the conference spurred the sessions and provided an insightful and excellent knowledge on the upcoming advances, research, and technology in neurology therapeutics.

On day 2, Jacqueline Sidman conducted a Workshop on “Unravelling defense mechanisms: How the subconscious mind releases early painful memories in order to heal physical, behavioral and emotional problems.” On day 2, Special session on “CNS drug development perspectives for young neurologists” was taken up by Marie Trad, Quintiles, France. Both the workshop and the special session discussed the major breakthroughs and developments in the field of neurology.

On day 3 symposium on “Stem cells for Neurological Disorders” by Guang-Xian Zhang, Thomas Jefferson University, USA discussed the Novel Therapies in Neurology.

The conference also provided an exclusive environment to the students for their development of research and gave them an opportunity to raise the profile of their research by poster presentations. Best poster awards were also given by the student council.

All accepted abstracts have been indexed in Journal of Neurology and Neurophysiology as a special issue.

Our special gratitude to our Exhibitor Proove  Biosciences and Media Partners ProHealth & Fitness, USA; The Sidman Institute, USA; Royal society of chemistry, USA.


Past Reports  Gallery  

PsychoAAD-2013

The International Conference on Psychology, Autism and Alzheimer’s Disease, organized by OMICS Group International was successfully held at Hilton San Antonio Airport, TX, USA during September 30-October 01, 2013. The conference was organized with the theme “Global Perspectives and Current Trends in Psychology"

The conference was marked with the presence of renowned scientists, talented young researchers, students and business delegates representing more than 20 different countries ultimately driving the event into the path of success.

OMICS Group International would like to convey a warm gratitude to all the Honorable guests of PsychoAAD-2013. The highlights of the conference were its educative and effectual keynote lectures by:

Joseph M. Rifkind, National Institute of Aging, USA

Jaykumar Rajdas, Stanford University, USA

H. Craig Heller, Stanford University, USA

George Perry, University of Texas at San Antonio, USA

Ronald J. Killiany, Boston University, USA

Mitchell Clionsky, Clionsky Neuro Systems, USA

Kalyani Gopal, American Psychological Association, USA

OMICS Group is grateful to Dr. Andrew V. Schally, Nobel Prize in Medicine 1977, for his time and dedication as Honourable Organizing Committee Member, for his exceptional support towards PsychoAAD 2013.

OMICS Group also took the privilege of felicitating PsychoAAD-2013 Organizing Committee, Editorial Board Members of Journal of Psychology & Psychotherapy, Journal of Alzheimer's Disease & Parkinsonism and Autism- Open Access, Keynote SpeakersChair and Co-Chairs whose support led the conference into the path of excellence.

Our special gratitude to our Collaborators Autism Community Network & Lebanese Psychological Association and Media Partners APPAC, Greece;  Med tube, USA;  ABP, Brazil; International Early Psychosis Association, Australia; Alzheimer’s Europe and Institute for forensic Criminology, Italy


Past Reports  Gallery  

Neuro-2012
Neuro-2012 Report

The International Conference & Exhibition on Neurology & Therapeutics, hosted by the OMICS Group was held on May 14-16, 2012 in Embassy Suites Las Vegas, USA. Generous response and active participation was received from the Editorial Board Members of OMICS Group Journals as well as from neurologists, researchers and leaders from pharma, government organizations who made this conference as one of most successful and productive events in 2012 from OMICS Group.

The conference was carried out through various sessions, in which the discussions were held on the following scientific tracks

  • Alzheimer's Disease
  • Neural Stem Cells and Gene or Cell Therapy
  • Diagnosis and Genetic Testing for Neurological Disorders
  • Neuroimmunology
  • Neuromics & Human Brain proteome
  • Perspectives in Neurology Research
  • Neurorehabilitation
  • Epilepsy
  • Current trends in Neurophysiology
  • Cerebral CSF Flow Studies
  • Diagnosis for cerebral infections
  • Clinical Neurophysiology & Electrophysiology

The conference was initiated with a series of keynote addresses by well-known speakers Dr. C. David James from University of California, San Francisco, USA, Dr. Asim Mahmood from Henry Ford Hospital, USA, Dr. Ahmad Salehi from Stanford Medical School, USA, Dr. Abha Chauhan from NYS Institute for Basic Research in Developmental Disabilities, USA.

All the above mentioned keynote speakers gave their energetic and fruitful contributions at Neuro-2012.

All accepted abstracts have been indexed in OMICS Group Journal of Neurology & Neurophysiology as a special issue
 


Past Reports  Gallery  

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date October 26-27, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2
Poster Opportunity Available

Media Partners

Conferenceseries Destinations